An analysis of tumor necrosis factor α gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection

被引:35
作者
Thio, CL
Goedert, JJ
Mosbruger, T
Vlahov, D
Strathdee, SA
O'Brien, S
Astemborski, J
Thomas, DL
机构
[1] Johns Hopkins Univ, Dept Med, Baltimore, MD 21231 USA
[2] NCI, Viral Epidemiol Branch, Rockville, MD USA
[3] New York Acad Med, New York, NY USA
[4] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21231 USA
[5] Lab Genom Divers, Frederick, MD USA
关键词
TNF; viral hepatitis; genetics; infectious diseases; genetic epidemiology;
D O I
10.1038/sj.gene.6364072
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The cytokine tumor necrosis factor alpha (TNF-alpha) is important in generating an immune response against a hepatitis C virus (HCV) infection. The functions of TNF-alpha may be altered by single-nucleotide polymorphisms (SNPs) in its gene, TNF. We hypothesized that SNPs in TNF may be important in determining the outcome of an HCV infection. To test this hypothesis, we typed nine TNF SNPs in a cohort of individuals with well-defined HCV outcomes. Three of these SNPs were typed in a second cohort. Data were analyzed using logistic regression stratifying by ethnicity, since rates of HCV clearance differ in black subjects versus white subjects. The SNP -863A was associated with viral clearance in black subjects (odds ratios (OR) 0.52, 95% confidence interval (CI) 0.29-0.93). Furthermore, the common wild-type haplotype -863C/-308G was associated with viral persistence in black subjects (OR 1,91, 95% Cl 1.24-2.95). These findings were independent of linkage with human leukocyte antigen (HLA) alleles. Further study of this polymorphism and haplotype is needed to understand these associations and the role of TNF-alpha in determining outcomes of HCV infection.
引用
收藏
页码:294 / 300
页数:7
相关论文
共 43 条
[41]   Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation [J].
Wilson, AG ;
Symons, JA ;
McDowell, TL ;
McDevitt, HO ;
Duff, GW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3195-3199
[42]   Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection [J].
Yee, LJ ;
Tang, YM ;
Gibson, AW ;
Kimberly, R ;
van Leeuwen, DJ ;
Kaslow, RA .
HEPATOLOGY, 2001, 33 (03) :708-712
[43]   Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection [J].
Yee, LJ ;
Tang, J ;
Herrera, J ;
Kaslow, RA ;
van Leeuwen, DJ .
GENES AND IMMUNITY, 2000, 1 (06) :386-390